Background characteristics of the patient cohort with stage I-IIIB NSCLC included in this study and candidates for radical chemo-radiotherapy (carboplatin/paclitaxel or cisplatin/etoposide).
收藏数据链接：
官方服务：
资源简介：
Quantitative data are presented as means ± S.E.M.
创建时间：
2015-12-03
